As this is the last post of the year, we would firstly like to wish you and your loved ones a joyful Christmas and a very happy new year. Before that, as we are about to enter January, the month of the double-faced god Janus facing both back and forward, we should first take a look at the past year before turning our attention to the year to come.
2017 has been an eventful year. Despite a shaky start, overall it has been a very good year for Ageas with the share price gaining 9% since the beginning of the year.
Financial markets have enjoyed a robust performance with all the major indices continuing their upwards march and US indices hitting all-time highs. Despite a series of natural disasters in the U.S. and geopolitical concerns over North Korea, Brexit, Catalonia or the rise of the far right in Germany, the market focus remained on the healthy economic fundamentals.
In this buoyant environment, not only did Ageas perform well, but it also outperformed both the Stoxx Insurance index (+7.4%) and the Euro Stoxx 50 Index (+8.8%).
Yet the year started on a difficult note with the Group’s full year 2016 net result suffering two blows in a row: first a preliminary announcement that exceptional items in the UK and in Asia would negatively impact the result by EUR 137 million and later on a post-closing adjustment of an additional EUR 100 million due to the review of the Ogden rate in the UK.
Fortunately, solid results have sustained our share price over the year. For the first nine months of 2017, Ageas reported an excellent insurance net result of EUR 686 million, up 16% scope-on-scope compared to last year, reflecting a strong operational performance with an operating margin in guaranteed products at 106 bps and a combined ratio below 95%. Although investors’ attention was somewhat distracted this year from the Group’s strong performance by questions raised by the first time disclosure of free capital generation figures, the explanation provided by management helped ease concerns. Also on a positive note, the announcement in August of a new share buy-back programme for an amount of EUR 200 million was welcomed by the market.
2017 was also marked by one or two setbacks, more specifically when the Amsterdam Court of Appeal did not declare the Fortis Settlement binding. This was a major disappointment but, after months of hard work, we reached an amended settlement agreement in December with not only the initial signatories but also with one of the previously main opposing parties. We are hopeful that this agreement takes into account the Court's main concerns, whilst offering a fair solution for all affected by the past events.
Also this year, Ageas announced in July the divestment of the Italian activities, through the sale of its 50% share in Cargeas, its Italian Non-Life operation. This divestment in a country where the Group has a limited market share is in line with Ageas's strategy to concentrate its efforts on markets where it holds stronger positions or where growth prospects are better. The transaction is anticipated to close before the end of the year.
Ageas’s strong year is also reflected in the substantial increase in the number of analysts covering our share which has almost doubled from 11 at the beginning of the year to 20 analysts today. Out of the 18 analysts publicly disclosing their recommendation, 10 have a positive recommendation, 5 are neutral and only 3 analysts have a negative recommendation on Ageas shares.
But enough of the past, it is now time to focus on the future. And 2018 should be an important year for Ageas on several levels.
Firstly, in 2018 we hope that the revised Settlement will be declared binding by the Court. This would bring this long outstanding dispute to a final closure and would represent a major step in solving the remaining legacies from the past, allowing the group to focus entirely on the future.
Secondly, 2018 is also a key year for our Belgian entity, AG Insurance, as BNP Paribas has the possibility in the first half of the year to exercise its put option on the 25% stake it owns in AG Insurance. In 2018 there could also be discussions taking place with BNP Paribas regarding the renewal of the distribution agreement.
Last but not least, 2018 is the final year of our 3 year strategy “Ambition 2018”. The plan was to continue growing our business in new and existing markets, offering the right insurance products to our customers, while rigorously working towards our financial targets.
In a nutshell, a lot to be happy about in 2017 and a lot to expect from 2018!
Happy New Year indeed!

